Responses
E-Posters
E-Poster Viewing
EPV129/#529 Long-term clinical and economic value of pembrolizumab + lenvatinib compared with chemotherapy in previously treated advanced endometrial cancer patients in Sweden: a cost-effectiveness analysis
Compose a Response to This Article
Other responses
No responses have been published for this article.